又有两家鄂企向港交所发起冲击。武汉大众口腔医疗股份有限公司(下称“大众口腔”)、翰思艾泰生物医药科技(武汉)股份有限公司(下称“翰思艾泰”)日前接连向港交所递交上市申请,两家企业均是第二次递表港交所。相关分析认为,目前港交所简化上市流程,同时今年以来港股市场走势较为强劲,募资压力相对轻松,有利于获得更好的估值。大众口腔新三板退市转战港股大众口腔成立于2007年,招股书显示,截至2025年5月20日...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.